Researchers advance the use of cerium/lanthanum-134 for medical scans in actinium-225 cancer therapy.
Hard to produce in quantities and purities appropriate for human use, scandium radioisotopes have potential for imaging cancer.
An easy-to-use system can increase the availability of PET imaging agents to more patients.
Research advances the chemistry and improves the purity of isotopes for targeted alpha therapy used in the treatment of cancers.
Scientists can tune the strength of astatine-211 bonds with chemicals called ketones, laying the groundwork for a new class of radiopharmaceuticals.
A newly proposed approach aids chemical studies of rare, toxic, radioactive, and precious isotopes by requiring 1,000 times less material.
This new method individually separates heavy metals — an actinide chemist’s dream.
High-energy proton experiments optimize production of medical imaging isotopes while providing insight into how to protect astronauts from space radiation.
New production methods for cerium-134 advance technologies for imaging human disease and guiding treatment.
A high-speed, high-yield recovery approach for At-211 means improved availability of this cancer-treating isotope.